Weeks 9-12: Rapid improvement
Dosing is based on metabolic goals and tolerance, not thyroid nodule status
If keto can shift that ratio, preserving muscle while still producing significant fat loss, the combination addresses the single biggest criticism of GLP-1 therapy for body composition
Regulation of energy balance by leptin
In preclinical models, co-administration of bimagrumab or dual myostatin/activin A inhibitors with GLP-1R agonists preserves or increases muscle mass while enhancing fat loss, resulting in improved body composition and metabolic outcomes compared with GLP-1R agonist monotherapy [176]
Optimizing Your Diet While on Semaglutide Therapy A semaglutide-friendly diet prioritizes lean proteins, non-starchy vegetables, and whole grains while minimizing processed, fried, and high-fat items